Literature DB >> 21681651

Acute management of sick infants with suspected inborn errors of metabolism.

Neerja Gupta1, Madhulika Kabra.   

Abstract

Diagnosis of inborn errors of metabolism (IEM) such as an organic acidemia or urea cycle defects requires high index of suspicion in a critically ill infant as these conditions mimic common pediatric illnesses. Prompt initiation of the treatment is mandatory even if a definitive diagnosis is not established immediately. Initial screening investigations may give clues and help to classify these disorders in broad categories. It is of utmost importance to preserve samples for testing.

Entities:  

Mesh:

Year:  2011        PMID: 21681651     DOI: 10.1007/s12098-011-0422-0

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  3 in total

1.  Current strategies for the management of neonatal urea cycle disorders.

Authors:  M Summar
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

Review 2.  Inborn errors of metabolism in infancy: a guide to diagnosis.

Authors:  B K Burton
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

Review 3.  Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism.

Authors:  Hélène Ogier de Baulny
Journal:  Semin Neonatol       Date:  2002-02
  3 in total
  2 in total

1.  Use of continuous hemodiafiltration for the treatment of a neonate with hyperammonemia secondary to argininosuccinate lyase (ASAL) deficiency.

Authors:  Shilpee Raturi; Iyer Harohalli Venkatesh; N Karthik Nagesh; Praveen Venkatagiri
Journal:  Indian J Pediatr       Date:  2013-03-29       Impact factor: 1.967

2.  Guidelines for acute management of hyperammonemia in the Middle East region.

Authors:  Majid Alfadhel; Fuad Al Mutairi; Nawal Makhseed; Fatma Al Jasmi; Khalid Al-Thihli; Emtithal Al-Jishi; Moeenaldeen AlSayed; Zuhair N Al-Hassnan; Fathiya Al-Murshedi; Johannes Häberle; Tawfeg Ben-Omran
Journal:  Ther Clin Risk Manag       Date:  2016-03-31       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.